Cargando…

New therapeutic approaches to HGPS based on progerin inhibition

Detalles Bibliográficos
Autor principal:	Pellegrini, Camilla
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652570/ http://dx.doi.org/10.1186/1750-1172-10-S2-O8

Ejemplares similares

Antisense-Based Progerin Downregulation in HGPS-Like Patients’ Cells
por: Harhouri, Karim, et al.
Publicado: (2016)

Progerin, an Aberrant Spliced Form of Lamin A, Is a Potential Therapeutic Target for HGPS
por: Kim, Bae-Hoon, et al.
Publicado: (2023)

Development of a SMCs model from HGPS-iPS and proofs of principle
por: Ferreira, Lino
Publicado: (2015)

Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways
por: Clements, Craig S., et al.
Publicado: (2019)

MG132 Induces Progerin Clearance and Improves Disease Phenotypes in HGPS-like Patients’ Cells
por: Harhouri, Karim, et al.
Publicado: (2022)

Pluripotent stem cells for pathological modelling of Hutchinson-Gilford Progeria Syndrome (HGPS) and drug discovery
por: Nissan, Xavier
Publicado: (2015)

Efficient progerin clearance through autophagy induction and SRSF-1 downregulation in Hutchinson-Gilford Progeria Syndrome
por: Harhouri, Karim
Publicado: (2015)

Accelerated atherosclerosis in HGPS
por: Hamczyk, Magda R., et al.
Publicado: (2018)

Envisioning new targets and new approaches for molecular-based cancer therapeutics
por: Tainer, JA
Publicado: (2005)

The sequential binge: a new therapeutic approach for binge eating
por: Neveu, Remi, et al.
Publicado: (2015)

Albumin-based drug delivery as novel therapeutic approach for rheumatoid arthritis
por: Wunder, A, et al.
Publicado: (2003)

New look at the role of progerin in skin aging
por: Skoczyńska, Anna, et al.
Publicado: (2015)

Investigation of a novel therapeutic approach in multiple sclerosis
por: Eniko, Biró, et al.
Publicado: (2013)

Progerin guilty of size discrimination
por: Leslie, Mitch
Publicado: (2013)

Adolescent bulimia nervosa (BN): a new therapeutic frontier
por: Hurst, Kim, et al.
Publicado: (2014)

The αvβ3 integrin as a therapeutic target for inhibition of bone resorption
por: Dixon, SJ, et al.
Publicado: (2004)

The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities
por: Wang, Duolao, et al.
Publicado: (2011)

An evidence-based approach to the development and implementation of a podiatric rheumatology service within the New Zealand health sector
por: Rome, Keith, et al.
Publicado: (2011)

Axillary staging: new approaches and treatment of minimal disease
por: Peeters, MTFD Vrancken
Publicado: (2009)

P062 Identification of Octenidine (dihydrochloride) inhibiting fungal filamentation by the repurposing approach
por: Fang, Ting, et al.
Publicado: (2022)

Finding modifiable predictors of treatment dropout: the role of the therapeutic alliance, readiness to change and acceptance of treatment approach
por: Pannekoek, Louise, et al.
Publicado: (2015)

Interrogating of cancer genomes: towards more profile-based therapeutics
por: Carpten, John David
Publicado: (2012)

Cost-effectiveness of public health interventions - a new methodological approach
por: Feldman, Inna, et al.
Publicado: (2014)

Urinary tract infections during pregnancy – clinical picture and therapeutic approach in the Infectious Diseases Hospital of Iaşi (2009-2012)
por: Luca, Mihaela Cătălina, et al.
Publicado: (2013)

Copper nanocolloids: a new thrombus molecular imaging approach to ruptured plaque
por: Pan, Dipanjan, et al.
Publicado: (2012)

Translating breast cancer research into clinical practice — new approaches and better outcomes
por: Johnston, SRD
Publicado: (2006)

A new connection between VHL and cancer threads through progerin
por: Kennedy, Brian K
Publicado: (2013)

Therapeutic Strategies
por: Prabhakar, P
Publicado: (2013)

Promotion of tumor development in prostate cancer by progerin
por: Tang, Yong, et al.
Publicado: (2010)

S3.4a The repurposing approach identifies pitavastatin (calcium) making fluconazole fungicidal by inhibiting ergosterol synthesis
por: Li, Wanqian, et al.
Publicado: (2022)

Towards gene therapy against HIV-1: new therapeutic target in gag RNA accessible to ribozymes and RNA interference molecules
por: Gatignol, A, et al.
Publicado: (2014)

Accounting for intervention complexity in rcts in surgery: new approaches for intervention definition and methods for monitoring fidelity
por: Blencowe, Natalie, et al.
Publicado: (2013)

The Journal of Therapeutic Ultrasound
por: Gedroyc, Wladyslaw, et al.
Publicado: (2015)

Future therapeutic options
por: Reuser, Arnold
Publicado: (2013)

Screening MRI-based prediction model for therapeutic response of MR-HIFU ablation of uterine fibroids
por: Kim, Young-sun, et al.
Publicado: (2015)

The 19th EML as a global standard: an innovative approach or just an opportunity for new and effective medicines?
por: Magrini, Nicola, et al.
Publicado: (2015)

Irisin and the therapeutic benefits of exercise
por: Spiegelman, Bruce M, et al.
Publicado: (2012)

P068 Inhibition of Candida glabrata biofilm using the combination of a novel antifungal cyclic lipopeptide and azole: An in vitro synergistic approach
por: Madhuri, Madduri, et al.
Publicado: (2022)

KRIPO – a structure-based pharmacophores approach explains polypharmacological effects
por: Ritschel, Tina, et al.
Publicado: (2014)

Rifampicin-loaded silicone: a new approach to tuning release rate with self assembled monolayers and cast molding
por: Liang, Xuemei, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_4fr4j4cf6r49m3svn3f1l47rpk